Literature DB >> 26300552

Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Marta Marin-Argany1, Jofre Güell-Bosch2, Luis M Blancas-Mejía1, Sandra Villegas2, Marina Ramirez-Alvarado1,3.   

Abstract

Light chain (AL) amyloidosis is an incurable human disease, where the amyloid precursor is a misfolding-prone immunoglobulin light-chain. Here, we identify the role of somatic mutations in the structure, stability and in vitro fibril formation for an amyloidogenic AL-12 protein by restoring four nonconservative mutations to their germline (wild-type) sequence. The single restorative mutations do not affect significantly the native structure, the unfolding pathway, and the reversibility of the protein. However, certain mutations either decrease (H32Y and H70D) or increase (R65S and Q96Y) the protein thermal stability. Interestingly, the most and the least stable mutants, Q96Y and H32Y, do not form amyloid fibrils under physiological conditions. Thus, Q96 and H32 are key residues for AL-12 stability and fibril formation and restoring them to the wild-type residues preclude amyloid formation. The mutants whose equilibrium is shifted to either the native or unfolded states barely sample transient partially folded states, and therefore do not form fibrils. These results agree with previous observations by our laboratory and others that amyloid formation occurs because of the sampling of partially folded states found within the unfolding transition (Blancas-Mejia and Ramirez-Alvarado, Ann Rev Biochem 2013;82:745-774). Here we provide a new insight on the AL amyloidosis mechanism by demonstrating that AL-12 does not follow the established thermodynamic hypothesis of amyloid formation. In this hypothesis, thermodynamically unstable proteins are more prone to amyloid formation. Here we show that within a thermal stability range, the most stable protein in this study is the most amyloidogenic protein.
© 2015 The Protein Society.

Entities:  

Keywords:  aggregation; immunoglobulin fold; light chain amyloidosis; protein misfolding; somatic mutations; thermodynamics

Mesh:

Substances:

Year:  2015        PMID: 26300552      PMCID: PMC4622216          DOI: 10.1002/pro.2790

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.

Authors:  M Ramirez-Alvarado; J S Merkel; L Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

Review 3.  Protein misfolding, functional amyloid, and human disease.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

Review 4.  Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.

Authors:  Mark R Wilson; Justin J Yerbury; Stephen Poon
Journal:  Mol Biosyst       Date:  2007-11-19

5.  Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.

Authors:  Mikael Lindgren; Karin Sörgjerd; Per Hammarström
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

6.  The molecular basis for the chemical denaturation of proteins by urea.

Authors:  Brian J Bennion; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

7.  Mechanism of thioflavin T binding to amyloid fibrils.

Authors:  Ritu Khurana; Chris Coleman; Cristian Ionescu-Zanetti; Sue A Carter; Vinay Krishna; Rajesh K Grover; Raja Roy; Shashi Singh
Journal:  J Struct Biol       Date:  2005-09       Impact factor: 2.867

8.  Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.

Authors:  D P Davis; G Gallo; S M Vogen; J L Dul; K L Sciarretta; A Kumar; R Raffen; F J Stevens; Y Argon
Journal:  J Mol Biol       Date:  2001-11-09       Impact factor: 5.469

9.  Alanine scanning mutagenesis of Abeta(1-40) amyloid fibril stability.

Authors:  Angela D Williams; Shankaramma Shivaprasad; Ronald Wetzel
Journal:  J Mol Biol       Date:  2006-01-30       Impact factor: 5.469

10.  Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains.

Authors:  J L Dul; D P Davis; E K Williamson; F J Stevens; Y Argon
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  14 in total

1.  Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.

Authors:  Luis M Blancas-Mejía; Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2017-01-24       Impact factor: 3.162

2.  Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2016-05-16       Impact factor: 3.162

3.  sw ApoMb Amyloid Aggregation under Nondenaturing Conditions: The Role of Native Structure Stability.

Authors:  Natalya S Katina; Vitalii A Balobanov; Nelly B Ilyina; Victor D Vasiliev; Victor V Marchenkov; Anatoly S Glukhov; Alexey D Nikulin; Valentina E Bychkova
Journal:  Biophys J       Date:  2017-09-05       Impact factor: 4.033

4.  Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.

Authors:  Pinaki Misra; Luis M Blancas-Mejia; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2019-07-09       Impact factor: 3.162

5.  Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.

Authors:  Kathrin Andrich; Ute Hegenbart; Christoph Kimmich; Niraja Kedia; H Robert Bergen; Stefan Schönland; Erich Wanker; Jan Bieschke
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

6.  A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.

Authors:  Daniele Peterle; Elena S Klimtchuk; Thomas E Wales; Florian Georgescauld; Lawreen H Connors; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2021-10-19       Impact factor: 5.469

Review 7.  Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis.

Authors:  Emily Lewkowicz; Olga Gursky
Journal:  Biophys Chem       Date:  2021-10-14       Impact factor: 3.628

Review 8.  Immunoglobulin light chain amyloid aggregation.

Authors:  Luis M Blancas-Mejia; Pinaki Misra; Christopher J Dick; Shawna A Cooper; Keely R Redhage; Michael R Bergman; Torri L Jordan; Khansaa Maar; Marina Ramirez-Alvarado
Journal:  Chem Commun (Camb)       Date:  2018-09-20       Impact factor: 6.222

9.  Early events in light chain aggregation at physiological pH reveal new insights on assembly, stability, and aggregate dissociation.

Authors:  Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2021-02-03       Impact factor: 7.141

10.  Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.

Authors:  Sujoy Mukherjee; Simon P Pondaven; Kieran Hand; Jillian Madine; Christopher P Jaroniec
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.